1
|
Majid SA, Mir JM, Paul S, Akhter M, Parray H, Ayoub R, Shalla AH. Experimental and molecular topology-based biological implications of Schiff base complexes: a concise review. REV INORG CHEM 2019. [DOI: 10.1515/revic-2018-0023] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
AbstractThis review is a gentle introduction toward Schiff bases with special attention to bioinorganic aspects. Depending on the nature of condensation moieties (ketonic or aldehydic) with primary amine, a large number of novel compounds are reported every year with applicability in various material science aspects. Herein, a burgeoning literature overview is presented to provide a salient discussion of the current status of these molecular systems. Schiff bases are designed depending on the particular desirable properties. For instance, to enlighten a biologically relevant molecule, it is always appreciated when a prepared compound shows biological membrane crossing and nucleic acid linking potential. Under such purview, the Schiff base functional group can serve as an enhancer of biomembrane traversing capability. In addition to various other catalytic aspects, the type of disease to be encountered also matters. Nowadays, theoretical chemistry is applied before synthesizing a compound of this sort and fruitful results are first depicted and, if found feasible, a suitable synthetic route is followed to synthesize Schiff base compounds. Molecular charge topology analysis under theoretical expression is analyzed generally to predict the biological relevance of a molecule.
Collapse
Affiliation(s)
- Sheikh Abdul Majid
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Jan Mohammad Mir
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Shazia Paul
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Mymoona Akhter
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Hashim Parray
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Romey Ayoub
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| | - Aabid Hussain Shalla
- Department of Chemistry, Islamic University of Science and Technology, Awantipora, Pulwama, Jammu and Kashmir 192122, India
| |
Collapse
|
2
|
Del Carpio E, Hernández L, Ciangherotti C, Villalobos Coa V, Jiménez L, Lubes V, Lubes G. Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications. Coord Chem Rev 2018; 372:117-140. [PMID: 32226092 PMCID: PMC7094547 DOI: 10.1016/j.ccr.2018.06.002] [Citation(s) in RCA: 56] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 06/03/2018] [Indexed: 12/11/2022]
Abstract
In the last 30 years, since the discovery that vanadium is a cofactor found in certain enzymes of tunicates and possibly in mammals, different vanadium-based drugs have been developed targeting to treat different pathologies. So far, the in vitro studies of the insulin mimetic, antitumor and antiparasitic activity of certain compounds of vanadium have resulted in a great boom of its inorganic and bioinorganic chemistry. Chemical speciation studies of vanadium with amino acids under controlled conditions or, even in blood plasma, are essential for the understanding of the biotransformation of e.g. vanadium antidiabetic complexes at the physiological level, providing clues of their mechanism of action. The present article carries out a bibliographical research emphaticizing the chemical speciation of the vanadium with different amino acids and reviewing also some other important aspects such as its chemistry and therapeutical applications of several vanadium complexes.
Collapse
Key Words
- 2,2′-bipy, 2,2-bipyridine
- 6-mepic, 6-methylpicolinic acid
- Ad, adenosine
- Ala, alanine
- Ala-Gly, alanylglycine
- Ala-His, alanylhistidine
- Ala-Ser, alanylserine
- Amino acids
- Antidiabetics
- Antitumors
- Asp, aspartic acid
- BEOV, bis(ethylmaltolate)oxovanadium(IV)
- Chemical speciation
- Cys, cysteine
- Cyt, citrate
- DMF, N,N-dimethylformamide
- DNA, deoxyribonucleic acid
- EPR, Electron Paramagnetic Resonance
- G, Gauss
- Glu, glutamic acid
- Gly, glycine
- GlyAla, glycylalanine
- GlyGly, glycylglycine
- GlyGlyCys, glycylglycylcysteine
- GlyGlyGly, glycylglycylglycine
- GlyGlyHis, glycylglycylhistidine
- GlyPhe, glycylphenylalanine
- GlyTyr, glycyltyrosine
- GlyVal, glycylvaline
- HIV, human immunodeficiency virus
- HSA, albumin
- Hb, hemoglobin
- His, histidine
- HisGlyGly, histidylglycylglycine
- Ig, immunoglobulins
- Im, imidazole
- L-Glu(γ)HXM, l-glutamic acid γ-monohydroxamate
- LD50, the amount of a toxic agent (such as a poison, virus, or radiation) that is sufficient to kill 50 percent of population of animals
- Lac, lactate
- MeCN, acetonitrile
- NADH and NAD+, nicotinamide adenine dinucleotide
- NEP, neutral endopeptidas
- NMR, Nuclear Magnetic Resonance
- Ox, oxalate
- PI3K, phosphoinositide 3-kinase
- PTP1B, protein tyrosine phosphatase 1B
- Pic, picolinic acid
- Pro, proline
- Pro-Ala, prolylalanine
- RNA, ribonucleic acid
- SARS, severe acute respiratory syndrome
- Sal-Ala, N-salicylidene-l-alaninate
- SalGly, salicylglycine
- SalGlyAla, salicylglycylalanine
- Ser, serine
- T, Tesla
- THF, tetrahydrofuran
- Thr, threonine
- VBPO, vanadium bromoperoxidases
- VanSer, Schiff base formed from o-vanillin and l-serine
- Vanadium complexes
- acac, acetylacetone
- dhp, 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone
- dipic, dipicolinic acid
- dmpp, 1,2-dimethyl-3-hydroxy-4-pyridinonate
- hTf, transferring
- hpno, 2-hydroxypyridine-N-oxide
- l.m.m., low molecular mass
- mal, maltol
- py, pyridine
- sal-l-Phe, N-salicylidene-l-tryptophanate
- salGlyGly, N-salicylideneglycylglycinate
- salSer, N-salicylideneserinate
- salTrp, N-salicylidene-L tryptophanate
- salVal, N-salicylidene-l-valinate
- salophen, N,N′-bis(salicylidene)-o-phenylenediamine
- saltrp, N-salicylidene-l-tryptophanate
- γ-PGA, poly-γ-glutamic acid
Collapse
Affiliation(s)
- Edgar Del Carpio
- Laboratorio de Equilibrios en Solución, Universidad Simón Bolívar (USB), Apartado 89000, Caracas 1080 A, Venezuela
- Unidad de Química Medicinal, Facultad de Farmacia, Escuela “Dr. Jesús María Bianco”, Universidad Central de Venezuela, Venezuela
| | - Lino Hernández
- Laboratorio de Equilibrios en Solución, Universidad Simón Bolívar (USB), Apartado 89000, Caracas 1080 A, Venezuela
- Escuela de Quimica, Facultad de Ciencias, Universidad Central de Venezuela, Venezuela
| | - Carlos Ciangherotti
- Laboratorio de Neuropéptidos, Facultad de Farmacia, Escuela “Dr. Jesús María Bianco”, Universidad Central de Venezuela, Venezuela
- Laboratorio de Bioquímica, Facultad de Farmacia, Escuela “Dr. Jesús María Bianco”, Universidad Central de Venezuela, Venezuela
| | - Valentina Villalobos Coa
- Laboratorio de Equilibrios en Solución, Universidad Simón Bolívar (USB), Apartado 89000, Caracas 1080 A, Venezuela
| | - Lissette Jiménez
- Facultad de ingeniería Química, Universidad de Carabobo, Venezuela
| | - Vito Lubes
- Laboratorio de Equilibrios en Solución, Universidad Simón Bolívar (USB), Apartado 89000, Caracas 1080 A, Venezuela
| | - Giuseppe Lubes
- Laboratorio de Equilibrios en Solución, Universidad Simón Bolívar (USB), Apartado 89000, Caracas 1080 A, Venezuela
| |
Collapse
|
3
|
Scior T, Guevara-Garcia JA, Do QT, Bernard P, Laufer S. Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review. Curr Med Chem 2016; 23:2874-2891. [PMID: 26997154 PMCID: PMC5068500 DOI: 10.2174/0929867323666160321121138] [Citation(s) in RCA: 64] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Revised: 03/14/2016] [Accepted: 03/18/2016] [Indexed: 12/18/2022]
Abstract
Public academic research sites, private institutions as well as small companies have made substantial contributions to the ongoing development of antidiabetic vanadium compounds. But why is this endeavor not echoed by the globally operating pharmaceutical companies, also known as "Big Pharma"? Intriguingly, today's clinical practice is in great need to improve or replace insulin treatment against Diabetes Mellitus (DM). Insulin is the mainstay therapeutically and economically. So, why do those companies develop potential antidiabetic drug candidates without vanadium (vanadium- free)? We gathered information about physicochemical and pharmacological properties of known vanadium-containing antidiabetic compounds from the specialized literature, and converted the data into explanations (arguments, the "pros and cons") about the underpinnings of antidiabetic vanadium. Some discoveries were embedded in chronological order while seminal reviews of the last decade about the Medicinal chemistry of vanadium and its history were also listed for further understanding. In particular, the concepts of so-called "noncomplexed or free" vanadium species (i.e. inorganic oxido-coordinated species) and "biogenic speciation" of antidiabetic vanadium complexes were found critical and subsequently documented in more details to answer the question.
Collapse
Affiliation(s)
- Thomas Scior
- Department of Pharmacy, Faculty of Chemical Sciences, University Benemerita Universidad Autonoma de Puebla, P.O. Box: 72570, City of Puebla, Country Mexico.
| | | | | | | | | |
Collapse
|
4
|
Chatkon A, Chatterjee PB, Sedgwick MA, Haller KJ, Crans DC. Counterion Affects Interaction with Interfaces: The Antidiabetic Drugs Metformin and Decavanadate. Eur J Inorg Chem 2013. [DOI: 10.1002/ejic.201201345] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
5
|
Ulbricht C, Chao W, Costa D, Culwell S, Eichelsdoerfer P, Flanagan K, Guilford J, Higdon ERB, Isaac R, Mintzer M, Rusie E, Serrano JMG, Windsor RC, Woods J, Zhou S. An evidence-based systematic review of vanadium by the Natural Standard Research Collaboration. J Diet Suppl 2012; 9:223-51. [PMID: 22891992 DOI: 10.3109/19390211.2012.709365] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
An evidence-based systematic review of vanadium by the Natural Standard Research Collaboration consolidates the safety and efficacy data available in the scientific literature using a validated, reproducible grading rationale. This article includes written and statistical analysis of clinical trials, plus a compilation of expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing.
Collapse
Affiliation(s)
- Catherine Ulbricht
- Natural Standard Research Collaboration, Massachusetts GeneralHospital, Somerville, Massachusetts, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Pakchung AAH, Soe CZ, Lifa T, Codd R. Complexes formed in solution between vanadium(IV)/(V) and the cyclic dihydroxamic acid putrebactin or linear suberodihydroxamic acid. Inorg Chem 2011; 50:5978-89. [PMID: 21627146 PMCID: PMC3124108 DOI: 10.1021/ic1025119] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2010] [Indexed: 01/25/2023]
Abstract
An aerobic solution prepared from V(IV) and the cyclic dihydroxamic acid putrebactin (pbH(2)) in 1:1 H(2)O/CH(3)OH at pH = 2 turned from blue to orange and gave a signal in the positive ion electrospray ionization mass spectrometry (ESI-MS) at m/z(obs) 437.0 attributed to the monooxoV(V) species [V(V)O(pb)](+) ([C(16)H(26)N(4)O(7)V](+), m/z(calc) 437.3). A solution prepared as above gave a signal in the (51)V NMR spectrum at δ(V )= -443.3 ppm (VOCl(3), δ(V) = 0 ppm) and was electron paramagnetic resonance silent, consistent with the presence of [V(V)O(pb)](+). The formation of [V(V)O(pb)](+) was invariant of [V(IV)]:[pbH(2)] and of pH values over pH = 2-7. In contrast, an aerobic solution prepared from V(IV) and the linear dihydroxamic acid suberodihydroxamic acid (sbhaH(4)) in 1:1 H(2)O/CH(3)OH at pH values of 2, 5, or 7 gave multiple signals in the positive and negative ion ESI-MS, which were assigned to monomeric or dimeric V(V)- or V(IV)-sbhaH(4) complexes or mixed-valence V(V)/(IV)-sbhaH(4) complexes. The complexity of the V-sbhaH(4) system has been attributed to dimerization (2[V(V)O(sbhaH(2))](+) ↔ [(V(V)O)(2)(sbhaH(2))(2)](2+)), deprotonation ([V(V)O(sbhaH(2))](+) - H(+) ↔ [V(V)O(sbhaH)](0)), and oxidation ([V(IV)O(sbhaH(2))](0) -e(-) ↔ [V(V)O(sbhaH(2))](+)) phenomena and could be described as the sum of two pH-dependent vectors, the first comprising the deprotonation of hydroxamate (low pH) to hydroximate (high pH) and the second comprising the oxidation of V(IV) (low pH) to V(V) (high pH). Macrocyclic pbH(2) was preorganized to form [V(V)O(pb)](+), which would provide an entropy-based increase in its thermodynamic stability compared to V(V)-sbhaH(4) complexes. The half-wave potentials from solutions of [V(IV)]:[pbH(2)] (1:1) or [V(IV)]:[sbhaH(4)] (1:2) at pH = 2 were E(1/2) -335 or -352 mV, respectively, which differed from the expected trend (E(1/2) [VO(pb)](+/0) < V(V/IV)-sbhaH(4)). The complex solution speciation of the V(V)/(IV)-sbhaH(4) system prevented the determination of half-wave potentials for single species. The characterization of [V(V)O(pb)](+) expands the small family of documented V-siderophore complexes relevant to understanding V transport and assimilation in the biosphere.
Collapse
Affiliation(s)
- Amalie A. H. Pakchung
- Center for Heavy Metals Research, School of Chemistry and School of Medical Sciences (Pharmacology) and Bosch Institute, University of Sydney, New South Wales 2006, Australia
| | - Cho Zin Soe
- Center for Heavy Metals Research, School of Chemistry and School of Medical Sciences (Pharmacology) and Bosch Institute, University of Sydney, New South Wales 2006, Australia
| | - Tulip Lifa
- Center for Heavy Metals Research, School of Chemistry and School of Medical Sciences (Pharmacology) and Bosch Institute, University of Sydney, New South Wales 2006, Australia
| | - Rachel Codd
- Center for Heavy Metals Research, School of Chemistry and School of Medical Sciences (Pharmacology) and Bosch Institute, University of Sydney, New South Wales 2006, Australia
| |
Collapse
|
7
|
Formation and structure in aqueous solution of complexes between vanadium(V) and aminohydroxamic acids that potentiates vanadium’s insulinomimetic activity: l-glutamic γ-hydroxamic and l-aspartic-β-hydroxamic acids. Inorganica Chim Acta 2010. [DOI: 10.1016/j.ica.2010.05.033] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
8
|
Roess DA, Smith SML, Winter P, Zhou J, Dou P, Baruah B, Trujillo AM, Levinger NE, Yang X, Barisas BG, Crans DC. Effects of vanadium-containing compounds on membrane lipids and on microdomains used in receptor-mediated signaling. Chem Biodivers 2008; 5:1558-1570. [PMID: 18729092 DOI: 10.1002/cbdv.200890144] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
There is increasing evidence for the involvement of plasma membrane microdomains in insulin receptor function. Moreover, disruption of these structures, which are typically enriched in sphingomyelin and cholesterol, results in insulin resistance. Treatment strategies for insulin resistance include the use of vanadium (V) compounds which have been shown in animal models to enhance insulin responsiveness. One possible mechanism for insulin-enhancing effects might involve direct effects of V compounds on membrane lipid organization. These changes in lipid organization promote the partitioning of insulin receptors and other receptors into membrane microdomains where receptors are optimally functional. To explore this possibility, we have used several strategies involving V complexes such as [VO(2)(dipic)](-) (pyridin-2,6-dicarboxylatodioxovanadium(V)), decavanadate (V(10)O(28)(6-), V(10)), BMOV (bis(maltolato)oxovanadium(IV)), and [VO(saltris)](2) (2-salicylideniminato-2-(hydroxymethyl)-1,3-dihydroxypropane-oxovanadium(V)). Our strategies include an evaluation of interactions between V-containing compounds and model lipid systems, an evaluation of the effects of V compounds on lipid fluidity in erythrocyte membranes, and studies of the effects of V-containing compounds on signaling events initiated by receptors known to use membrane microdomains as signaling platforms.
Collapse
Affiliation(s)
- Deborah A Roess
- Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1872, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Neutral dioxovanadium(V) complexes of biomimetic hydrazones ONO donor ligands of bioinorganic and medicinal relevance: Synthesis via air oxidation of bis(acetylaceto-nato)oxovanadium(IV), characterization, biological activity and 3D molecular modeling. J Mol Struct 2007. [DOI: 10.1016/j.molstruc.2006.09.022] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
10
|
|
11
|
Haratake M, Fukunaga M, Ono M, Nakayama M. Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity. J Biol Inorg Chem 2005; 10:250-8. [PMID: 15806386 DOI: 10.1007/s00775-005-0634-8] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2004] [Accepted: 02/15/2005] [Indexed: 10/25/2022]
Abstract
We synthesized vanadyl (oxidation state +IV) and vanadate (oxidation state +V) complexes with the same hydroxamic acid derivative ligand, and assessed their glucose-lowering activities in relation to the vanadium biodistribution behavior in streptozotocin-induced diabetic mice. When the mice received an intraperitoneal injection of the complexes, the vanadate complex more effectively lowered the elevated glucose levels compared with the vanadyl one. The glucose-lowering effect of the vanadate complex was linearly related to its dose within the range from 2.5 to 7.5 mg V/kg. In addition, pretreatment of the vanadate complex induced a larger insulin-enhancing effect than the vanadyl complex. Both complexes were more effective than the corresponding inorganic vanadium compounds. The vanadyl and vanadate complexes, but not the inorganic vanadium compounds, resulted in almost the same organ vanadium distribution. Consequently, the observed differences in the insulin-like activity between the complexes would reflect the potency of the two compounds in the +IV and +V oxidation states in the subcellular region.
Collapse
Affiliation(s)
- Mamoru Haratake
- Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8521, Japan.
| | | | | | | |
Collapse
|
12
|
Shukla R, Barve V, Padhye S, Bhonde R. Synthesis, structural properties and insulin-enhancing potential of bis(quercetinato)oxovanadium(IV) conjugate. Bioorg Med Chem Lett 2004; 14:4961-5. [PMID: 15341960 DOI: 10.1016/j.bmcl.2004.07.020] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2004] [Revised: 07/05/2004] [Accepted: 07/11/2004] [Indexed: 10/26/2022]
Abstract
An oxovanadium complex of quercetin (2), exhibits highly potent insulin-enhancing activity in streptozotocin-induced diabetic mice. It also mimics mitogenic potential of insulin as evaluated by [H(3)]thymidine uptake assay making an effective, orally active insulin-enhancing agent for the treatment of both type 1 and type 2 diabetes without any noticeable toxic effects.
Collapse
Affiliation(s)
- Ruchi Shukla
- National Centre for Cell Science, Pune University Campus, Pune 411007, India
| | | | | | | |
Collapse
|
13
|
He Z, Jiang T, Wang Z, Levi M, Li J. Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. Am J Physiol Endocrinol Metab 2004; 287:E424-30. [PMID: 15100094 DOI: 10.1152/ajpendo.00568.2003] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Carbohydrate response element-binding protein (ChREBP) is a rat homolog of human Williams-Beuren syndrome region 14 and a member of the basic helix-loop-helix leucine zipper transcription factor family. Its activation was found to be inducible by carbohydrate in the liver nuclear extracts from rats fed a high-sucrose diet. ChREBP is able to bind to the carbohydrate response element on the promoter of L-type pyruvate kinase and initiate the gene transcription. The detailed expression profile and transcriptional regulation of the ChREBP gene in adipocytes have not been characterized. In the present study, we provide evidence showing that 1) the ChREBP gene is expressed in differentiated 3T3-L1 adipocytes and rat adipose tissue; 2) insulin, glucose, and the antidiabetic agent troglitazone can significantly upregulate the gene expression of ChREBP in 3T3-L1 adipocytes, whereas free fatty acids suppress its expression in this cell type; 3) fasting followed by refeeding with a high-carbohydrate diet resulted in a 10-fold increase of ChREBP mRNA level in rat adipose tissue; and 4) ChREBP expression in adipose tissue is not significantly affected by the diabetic state. Taken together, the results we present are consistent with the idea that ChREBP is an important modulator of adipocyte biology and that its expression in adipose tissue is subject to combined regulation by glucose and insulin in vivo. The induction of ChREBP may serve as a novel pharmacological pathway for troglitazone-mediated hypoglycemic effects in vivo.
Collapse
Affiliation(s)
- Zhibin He
- Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA
| | | | | | | | | |
Collapse
|
14
|
Crans DC, Smee JJ, Gaidamauskas E, Yang L. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev 2004; 104:849-902. [PMID: 14871144 DOI: 10.1021/cr020607t] [Citation(s) in RCA: 987] [Impact Index Per Article: 49.4] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Debbie C Crans
- Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523-1872, USA.
| | | | | | | |
Collapse
|
15
|
Vanadium(IV) and vanadium(V) complexes of dipicolinic acid and derivatives. Synthesis, X-ray structure, solution state properties. Inorganica Chim Acta 2003. [DOI: 10.1016/s0020-1693(03)00430-4] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
16
|
Kawabe K, Sasagawa T, Yoshikawa Y, Ichimura A, Kumekawa K, Yanagihara N, Takino T, Sakurai H, Kojima Y. Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids. J Biol Inorg Chem 2003; 8:893-906. [PMID: 14551811 DOI: 10.1007/s00775-003-0489-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2003] [Accepted: 08/19/2003] [Indexed: 10/26/2022]
Abstract
Structures, chemical properties, and in vitro insulinomimetic activities of new vanadyl [oxovanadium(IV), VO(2+)] complexes with five tripodal ligands containing an imidazole functionality were examined. The ligands, N-(carboxymethyl)- N-(4-imidazolylmethyl)amino acids, contain glycine, ( S)- and ( R)-alanine, and ( S)- and ( R)-leucine residues. The molecular structures of the latter four alanine- and leucine-containing complexes were determined by X-ray analysis. The coordination geometry around each vanadium center was octahedral, where an imino nitrogen occupied the apical site and two carboxylate oxygens, an imidazole nitrogen, and a water molecule coordinated in the equatorial plane. The spectroscopic properties of the complexes were characterized by means of IR, electronic absorption, and CD spectra. Acid dissociation constants (p K(a)) and protonation sites of the ligands were determined by a combination of potentiometric titrations and (1)H NMR spectra. The potentiometric study demonstrated that stability constants (log beta) were not so different among the present complexes (14.0-14.9) and a species of molecular complex with a 1:1 metal:ligand ratio existed predominantly at physiological pH 7.4. EPR parameters indicated that the species at pH 7.4 had an octahedral structure similar to the complex in the solid state. On the other hand, an EPR study in phosphate buffer (pH 7.4) suggested that inorganic phosphate coordinated to the vanadium center instead of the imidazole group in the presence of excess phosphate ion. Cyclic voltammograms in the phosphate buffer showed chemically reversible oxidation waves, whereas irreversible oxidation waves were observed in non-coordinating HEPES buffer. Moreover, the oxidation potential of each complex in phosphate buffer was more positive than that in HEPES buffer. Partition coefficients of the present complexes in a n-octanol/saline system were very low, probably due to hydrophilicity of the imidazole group. The in vitro insulinomimetic activities were estimated on the basis of the ability of the complexes to inhibit epinephrine-stimulated free fatty acid release from isolated rat adipocytes. The achiral glycine-derivative complex exhibited the highest insulinomimetic activity, which was higher than that of VOSO(4) as a positive control. Putting our previous observations together, it was found that the vanadyl complexes with tetradentate amino acid derivatives having no alkyl side chain tend to have high in vitro insulinomimetic activity.
Collapse
Affiliation(s)
- Kenji Kawabe
- Department of Chemistry, Graduate School of Science, Osaka City University, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Shechter Y, Tsubery H, Fridkin M. Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats. Biochem Biophys Res Commun 2003; 307:315-21. [PMID: 12859957 DOI: 10.1016/s0006-291x(03)01200-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
FMS(3)-insulin (2-sulfo-9-fluorenylmethoxycarbonyl)(3)-insulin is a water soluble, inactive-reactivated derivative of insulin with protracted action in vivo. In this study we find that FMS(3)-insulin preserves insulin's capacity to crystallize when associated with Zn(2+) ions or with basic protamine. Zinc or protamine suspended preparations of FMS(3)-insulin manifest substantially prolonged, blood glucose-lowering pharmacokinetic profiles in STZ-treated rats (STZ-rats). A dose of up to 1mg suspended FMS(3)-insulin/STZ rat can be subcutaneously administered with no hypoglycemic episodes at any time point after administration. This dose yielded glucose-lowering profiles with t(1/2) values at the range of 50-70h, turning catabolic STZ-rats into anabolic ones over a period of 2-3 days. The obtained glucose-lowering patterns exceeded 7-8 times in duration those produced by nonhypoglycemic doses of NPH-insulin. In summary, subcutaneous administration of suspended insulin prodrugs, such as FMS(3)-insulin, can bring about prolonged, nonhypoglycemic glucose-lowering profiles, unattainable with insulin preparations, which are known to be active at the time of administration.
Collapse
Affiliation(s)
- Yoram Shechter
- Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel.
| | | | | |
Collapse
|
18
|
Sakurai H, Yasui H, Adachi Y. The therapeutic potential of insulin-mimetic vanadium complexes. Expert Opin Investig Drugs 2003; 12:1189-203. [PMID: 12831353 DOI: 10.1517/13543784.12.7.1189] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Throughout the world, the number of patients suffering from diabetes mellitus (DM) is increasing on a daily basis, probably due to change in lifestyle. DM is mainly classified as either insulin-dependent Type 1 or non-insulin-dependent Type 2, according to the definition of WHO. To treat DM, which has many severe complications, several types of insulin preparations and synthetic drugs for Type 1 and Type 2 DM, respectively, have been developed and are in clinical use. However, there are several problems concerning the insulin preparations and synthetic drugs, such as physical and mental pain due to daily insulin injections and defects involving side effects, respectively. Consequently, a new class of therapeutic agents is anticipated. For this purpose, vanadium-containing complexes are expected to treat or improve both types of DM by using unique characteristics of the transition metal. In this article, the current state of research on insulin-mimetic vanadium complexes are reviewed, with special focus on the paramagnetic vanadyl (+4 oxidation state of vanadium) complexes with different coordination modes. To analyse the blood glucose-lowering effects of the vanadyl complexes, new results on the organ distribution and pharmacokinetic analysis of the vanadyl state in the blood of rats are also described.
Collapse
Affiliation(s)
- Hiromu Sakurai
- Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University, 5 Nakauchicho, Misasagi, Yamashinaku, Kyoto 607-8414, Japan.
| | | | | |
Collapse
|
19
|
Girón MD, Caballero JJ, Vargas AM, Suárez MD, Guinovart JJ, Salto R. Modulation of glucose transporters in rat diaphragm by sodium tungstate. FEBS Lett 2003; 542:84-8. [PMID: 12729903 DOI: 10.1016/s0014-5793(03)00352-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Oral administration of sodium tungstate is an effective treatment for diabetes in animal models. We examined the effects of 6 weeks of oral administration of tungstate on glucose transporters (GLUT) in streptozotocin-induced diabetic rat diaphragm. Diabetes decreased GLUT4 expression while tungstate treatment normalized not only GLUT4 protein but also GLUT4 mRNA in the diabetic rats. Furthermore, treatment increased GLUT4 protein in plasma and internal membranes, suggesting a stimulation of its translocation to the plasma membrane. Tungstate had no effect on healthy animals. There were no differences in the total amount of GLUT1 transporter in any group. We conclude that the normoglycemic effect of tungstate may be partly due to a normalization of the levels and subcellular localization of GLUT4, which should result in an increase in muscle glucose uptake.
Collapse
Affiliation(s)
- M D Girón
- Department of Biochemistry and Molecular Biology, School of Pharmacy, University of Granada, Campus de Cartuja sn, E-18071 Granada, Spain
| | | | | | | | | | | |
Collapse
|
20
|
Hindi S, Grossman DP, Goldwaser I, Shechter Y, Fridkin M. Potentiating vanadium-evoked glucose metabolism by novel hydroxamate derivatives. Int J Pept Res Ther 2002. [DOI: 10.1007/bf02447549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
21
|
Bell JH, Pratt RF. Formation and structure of 1:1 complexes between aryl hydroxamic acids and vanadate at neutral pH. Inorg Chem 2002; 41:2747-53. [PMID: 12005499 DOI: 10.1021/ic011193+] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Although aryl hydroxamic acids are well-known to form coordination complexes with vanadate (V(V)), the nature of these complexes at neutral pH and submillimolar concentrations, the conditions under which such complexes inhibit various serine amidohydrolases, is not well established. A series of qualitative and quantitative experiments, involving UV/vis, (1)H NMR, and (51)V NMR spectroscopies, established that both 1:1 and 1:2 vanadate/hydroxamate complexes form at pH 7.5, with the former dominating at submillimolar concentrations. Formation constants for the complexes of several aryl and alkyl hydroxamic acids were determined; for example, for benzohydroxamic acid, the stepwise formation constants of the 1:1 and 1:2 complexes were 3000 and 400 M(-1), respectively. The (51)V chemical shift of the 1:1 4-nitrobenzohydroxamic acid complex was -497 ppm, and that of its unsubstituted analogue was -498 ppm. A (1)H-(15)N HSQC spectrum of the 4-nitrobenzo-(15)N-hydroxamic acid/vanadate complex indicated the presence of an N-H group with (15)N and (1)H chemical shifts of 115 and 5.83 ppm, respectively. A (13)C NMR spectrum of the complex of 4-nitrobenzo-(13)C-hydroxamic acid with vanadate displayed a resonance at 170.1 ppm and thus a coordination-induced shift (CIS) of +3.8 ppm. In contrast, the CIS value of an established 1:2 complex, thought to contain chelated hydroxamic acid ligands, was +11.9 ppm. These spectral data led to the following structural picture of 1:1 complexes of vanadate and aryl hydroxamic acids. They contain penta- or hexa-coordinated vanadium. The ligand is in the hydroxamate rather than hydroximate form. The ligand is presumably bound to vanadium through the hydroxamic hydroxyl oxygen, but the hydroxamic acid carbonyl oxygen interacts weakly with vanadium. These species are the most likely candidates for the inhibitors of serine amidohydrolases found in vanadate/hydroxamic acid mixtures.
Collapse
Affiliation(s)
- Jason H Bell
- Department of Chemistry, Wesleyan University, Middletown, Connecticut 06459, USA
| | | |
Collapse
|
22
|
Goldwaser I, Qian S, Gershonov E, Fridkin M, Shechter Y. Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators. Mol Pharmacol 2000; 58:738-46. [PMID: 10999943 DOI: 10.1124/mol.58.4.738] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Several ligands, when complexed with vanadium, potentiate its insulinomimetic activity both in vivo and in vitro. We have recently found that L-Glu-gamma-monohydroxamate (HXM) and L-Asp(beta)HXM were especially potent in this regard. In the present study, we used vanadium-enriched adipose cells and cell-free experimental systems to determine the features of L-Glu(gamma)HXM and L-Asp(beta)HXM that turn these ligands into optimal-synergizing vanadium chelators. We found that L-Glu(gamma)HXM and L-Asp(beta)(HXM) possess the following characteristics: 1) They associate with vanadium(+5) at pH 7.2 within a narrow range of an apparent formation constant of 1.3 to 1.9 x 10(2) M(-1); 2) they have nearly the same binding affinity for the vanadyl(+4) cation and the vanadate(+5) anion at physiological pH values; and 3) they form intense ultraviolet absorbing complexes upon associating with vanadium(+4) at 1 and 3 M stoichiometry, respectively, at pH 3.0. Vanadium ligands lacking any of these three defined criteria synergize less effectively with vanadium to activate glucose metabolism.
Collapse
Affiliation(s)
- I Goldwaser
- Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel
| | | | | | | | | |
Collapse
|
23
|
Abstract
The chemistry of vanadium compounds that can be taken orally is very timely since a vanadium(IV) compound, KP-102, is currently in clinical trials in humans, and the fact that human studies with inorganic salts have recently been reported. VO(acac)2 and VO(Et-acac)2 (where acac is acetylacetonato and Et-acac is 3-ethyl-2,4-pentanedionato) have long-term in vivo insulin mimetic effects in streptozotocin induced diabetic Wistar rats. Structural characterization of VO(acac)2 and two derivatives, VO(Me-acac)2 and VO(Et-acac)2, in the solid state and solution have begun to delineate the size limits of the insulin-like active species. Oral ammonium dipicolinatooxovanadium(V) is a clinically useful hypoglycemic agent in cats with naturally occurring diabetes mellitus. This compound is particularly interesting since it represents the first time that a well-characterized organic vanadium compound with the vanadium in oxidation state five has been found to be an orally effective hypoglycemic agent in animals.
Collapse
Affiliation(s)
- D C Crans
- Department of Chemistry, College of Natural Sciences, Colorado State University, Fort Collins 80523-1872, USA.
| |
Collapse
|
24
|
Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y. Insulin-like effects of vanadium: basic and clinical implications. J Inorg Biochem 2000; 80:21-5. [PMID: 10885459 DOI: 10.1016/s0162-0134(00)00035-0] [Citation(s) in RCA: 112] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Most mammalian cells contain vanadium at a concentration of about 20 nM, the bulk of which is probably in the reduced vanadyl (+4) form. Although this trace element is essential and should be present in the diet in minute quantities, no known physiological role for vanadium has been found thus far. In the late 1970s the vanadate ion was shown to act as an efficient inhibitor of Na+,K+-ATPase as well as of other related phosphohydrolases. In 1980 vanadium was reported to mimic the metabolic effects of insulin in rat adipocytes. During the last decade, vanadium has been found to act in an insulin-like manner in all three main target tissues of the hormone, namely skeletal muscles, adipose, and liver. Subsequent studies revealed that the action of vanadium salts is mediated through insulin-receptor independent alternative pathway(s). The investigation of the antidiabetic potency of vanadium soon ensued. Vanadium therapy was shown to normalize blood glucose levels in STZ-rats and to cure many hyperglycemia-related deficiencies. Therapeutic effects of vanadium were then demonstrated in type II diabetic rodents, which do not respond to exogenously administered insulin. Finally, clinical studies indicated encouraging beneficial effects. A major obstacle, however, is overcoming vanadium toxicity. Recently, several organically chelated vanadium compounds were found more potent and less toxic than vanadium salts in vivo. Such a newly discovered organic chelator of vanadium is described in this review.
Collapse
Affiliation(s)
- I Goldwaser
- Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel
| | | | | | | | | |
Collapse
|
25
|
Hacking MA, Akkus H, van Rantwijk F, Sheldon RA. Lipase and esterase-catalyzed acylation of hetero-substituted nitrogen nucleophiles in water and organic solvents. Biotechnol Bioeng 2000; 68:84-91. [PMID: 10699875 DOI: 10.1002/(sici)1097-0290(20000405)68:1<84::aid-bit10>3.0.co;2-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The lipase- and esterase-catalyzed acylations of hydroxylamine and hydrazine derivatives with octanoic acid and ethyl octanoate are described. The influence of solvent and nucleophile on the initial reaction rate was investigated for a number of free and immobilized enzymes. Initial rates were highest in water, but the overall productivity was optimal in dioxane. Octanoic acid (250 g/L) was converted for 93% into the hydroxamic acid in 36 h with only 1% (w/w) Candida antarctica lipase B (Novozym 435) in dioxane at 40 degrees C. This translates to a catalyst productivity of 68.5 g. g(-1). day(-1) and a space time yield of 149 g. L(-1). day(-1), unprecedented figures in the direct reaction of an acid with a nitrogen nucleophile in an organic solvent.
Collapse
Affiliation(s)
- M A Hacking
- Laboratory of Organic Chemistry, Delft University of Technology, Julianalaan 136, 2628 BL Delft, The Netherlands
| | | | | | | |
Collapse
|